VP Venture Partners
Overview
VP Venture Partners is a Zurich-based venture capital firm that supports early-stage life science companies in Europe, focusing on medical devices, digital health, and diagnostics.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Diamens | Mar 2026 | Pre Seed | Co-investor |
| CollimateHealth | Jun 2026 | Seed | Co-investor |
| Hemotune AG | Mar 2024 | Series B Extension | Co-investor |
| Moonlight AI | May 2026 | Seed | Lead |
| Diamens | Mar 2026 | Pre Seed | Co-investor |
Key People
Julia Flötotto
Co-Founder CFO CTO
Annick Bay
Investment Manager
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is VP Venture Partners based?
VP Venture Partners is headquartered in Zurich, Switzerland.
When was VP Venture Partners founded?
VP Venture Partners was founded in 2020.
How many portfolio companies does VP Venture Partners have?
VP Venture Partners has 5 portfolio companies in Caplight's dataset.
What are some companies in VP Venture Partners's portfolio?
Portfolio companies visible on Caplight include Diamens, CollimateHealth, Hemotune AG, Moonlight AI, Diamens.
What was VP Venture Partners's most recent investment shown here?
VP Venture Partners's most recent investment in this portfolio sample was in CollimateHealth in 2026.
What sectors does VP Venture Partners focus on?
VP Venture Partners focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech.
What company stages does VP Venture Partners focus on?
VP Venture Partners typically invests at the Early stage.